Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is a publicly traded Healthcare sector company. As of May 21, 2026, SNOA trades at $1.13 with a market cap of $3.58M and a P/E ratio of -0.38. SNOA moved +4.46% today. Year to date, SNOA is -71.31%; over the trailing twelve months it is -67.48%. Its 52-week range spans $0.85 to $6.92. Rallies surfaces SNOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SNOA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SNOA recently traded at $1.13. Market cap is $3.58M. P/E ratio is -0.38. Revenue is $14.29M.
| Metric | Value |
|---|---|
| Price | $1.13 |
| Market Cap | $3.58M |
| P/E Ratio | -0.38 |
| EPS | $-2.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.92 |
| 52-Week Low | $0.85 |
| Volume | 2.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.29M |
| Net Income | $-2.91M |
| Gross Margin | 38.25% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $14.29M | $-2.91M | $-2.79 |
| 2024 | $12.73M | $-4.92M | $-0.53 |
| 2023 | $13.27M | $-5.18M | $-1.52 |
| 2022 | $12.63M | $-5.40M | $0.00 |
SNOA analyst coverage data. Average price target: $0.00.